175 related articles for article (PubMed ID: 36293413)
1. Improving Fmoc Solid Phase Synthesis of Human Beta Defensin 3.
Walewska A; Kosikowska-Adamus P; Tomczykowska M; Jaroszewski B; Prahl A; Bulaj G
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293413
[TBL] [Abstract][Full Text] [Related]
2. Engineering disulfide bonds of the novel human beta-defensins hBD-27 and hBD-28: differences in disulfide formation and biological activity among human beta-defensins.
Schulz A; Klüver E; Schulz-Maronde S; Adermann K
Biopolymers; 2005; 80(1):34-49. PubMed ID: 15625724
[TBL] [Abstract][Full Text] [Related]
3. An optimized Fmoc synthesis of human defensin 5.
Vernieri E; Valle J; Andreu D; de la Torre BG
Amino Acids; 2014 Feb; 46(2):395-400. PubMed ID: 24311274
[TBL] [Abstract][Full Text] [Related]
4. Different dynamics and pathway of disulfide bonds reduction of two human defensins, a molecular dynamics simulation study.
Zhang L
Proteins; 2017 Apr; 85(4):665-681. PubMed ID: 28106297
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of a dicarba analogue of human β-defensin-1 using a combined ring closing metathesis--native chemical ligation strategy.
Heapy AM; Williams GM; Fraser JD; Brimble MA
Org Lett; 2012 Feb; 14(3):878-81. PubMed ID: 22239540
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the disulfide motif in BNBD-12, an antimicrobial beta-defensin peptide from bovine neutrophils.
Tang YQ; Selsted ME
J Biol Chem; 1993 Mar; 268(9):6649-53. PubMed ID: 8454636
[TBL] [Abstract][Full Text] [Related]
7. Influence of disulfide bonds in human beta defensin-3 on its strain specific activity against Gram-negative bacteria.
Nehls C; Böhling A; Podschun R; Schubert S; Grötzinger J; Schromm A; Fedders H; Leippe M; Harder J; Kaconis Y; Gronow S; Gutsmann T
Biochim Biophys Acta Biomembr; 2020 Aug; 1862(8):183273. PubMed ID: 32171739
[TBL] [Abstract][Full Text] [Related]
8. Human β-defensin 4 with non-native disulfide bridges exhibit antimicrobial activity.
Sharma H; Nagaraj R
PLoS One; 2015; 10(3):e0119525. PubMed ID: 25785690
[TBL] [Abstract][Full Text] [Related]
9. Native Chemical Ligation via N-Acylurea Thioester Surrogates Obtained by Fmoc Solid-Phase Peptide Synthesis.
Palà-Pujadas J; Blanco-Canosa JB
Methods Mol Biol; 2020; 2133():141-161. PubMed ID: 32144666
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of pseudoproline derivatives allows the facile synthesis of human IAPP, a highly amyloidogenic and aggregation-prone polypeptide.
Abedini A; Raleigh DP
Org Lett; 2005 Feb; 7(4):693-6. PubMed ID: 15704927
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity.
Klüver E; Schulz-Maronde S; Scheid S; Meyer B; Forssmann WG; Adermann K
Biochemistry; 2005 Jul; 44(28):9804-16. PubMed ID: 16008365
[TBL] [Abstract][Full Text] [Related]
12. Automated Fmoc-based solid-phase synthesis of peptide thioesters with self-purification effect and application in the construction of immobilized SH3 domains.
Mende F; Beisswenger M; Seitz O
J Am Chem Soc; 2010 Aug; 132(32):11110-8. PubMed ID: 20662535
[TBL] [Abstract][Full Text] [Related]
13. Scope and Limitations of Fmoc Chemistry SPPS-Based Approaches to the Total Synthesis of Insulin Lispro via Ester Insulin.
Dhayalan B; Mandal K; Rege N; Weiss MA; Eitel SH; Meier T; Schoenleber RO; Kent SB
Chemistry; 2017 Jan; 23(7):1709-1716. PubMed ID: 27905149
[TBL] [Abstract][Full Text] [Related]
14. Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity.
Bauer F; Schweimer K; Klüver E; Conejo-Garcia JR; Forssmann WG; Rösch P; Adermann K; Sticht H
Protein Sci; 2001 Dec; 10(12):2470-9. PubMed ID: 11714914
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction.
García JR; Jaumann F; Schulz S; Krause A; Rodríguez-Jiménez J; Forssmann U; Adermann K; Klüver E; Vogelmeier C; Becker D; Hedrich R; Forssmann WG; Bals R
Cell Tissue Res; 2001 Nov; 306(2):257-64. PubMed ID: 11702237
[TBL] [Abstract][Full Text] [Related]
16. Chemical synthesis of beta-defensins and LEAP-1/hepcidin.
Klüver E; Schulz A; Forssmann WG; Adermann K
J Pept Res; 2002 Jun; 59(6):241-8. PubMed ID: 12010514
[TBL] [Abstract][Full Text] [Related]
17. Discovery of new human beta-defensins using a genomics-based approach.
Jia HP; Schutte BC; Schudy A; Linzmeier R; Guthmiller JM; Johnson GK; Tack BF; Mitros JP; Rosenthal A; Ganz T; McCray PB
Gene; 2001 Jan; 263(1-2):211-8. PubMed ID: 11223260
[TBL] [Abstract][Full Text] [Related]
18. Solution structure and activity of the synthetic four-disulfide bond Mediterranean mussel defensin (MGD-1).
Yang YS; Mitta G; Chavanieu A; Calas B; Sanchez JF; Roch P; Aumelas A
Biochemistry; 2000 Nov; 39(47):14436-47. PubMed ID: 11087396
[TBL] [Abstract][Full Text] [Related]
19. The human beta-defensin-1 and alpha-defensins are encoded by adjacent genes: two peptide families with differing disulfide topology share a common ancestry.
Liu L; Zhao C; Heng HH; Ganz T
Genomics; 1997 Aug; 43(3):316-20. PubMed ID: 9268634
[TBL] [Abstract][Full Text] [Related]
20. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.
Valore EV; Park CH; Quayle AJ; Wiles KR; McCray PB; Ganz T
J Clin Invest; 1998 Apr; 101(8):1633-42. PubMed ID: 9541493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
